Dulling the Scythe: New Approaches to Managing Sickle Cell Disease

Sickle cell disease impacts the lives of an estimated 100,000 Americans. The impact ranges from mild lab abnormalities to painful vaso-occlusive crisis (VOC), pulmonary hypertension, and strokes. Management strategies for VOC include opioids, NSAIDs, and other adjuvant agents. Newer scientific discoveries are attempting to prevent sickling, VOC occurrences, and other negative sequelae. This discussion will bring focus to the newer strategies at prevention and management of sickle cell disease.

Learning Objectives

  • Recall the pathophysiology of sickle cell disease and complications
  • Review the most recent medication additions to the management of sickle cell disease
  • Summarize the strategies for acute, chronic and acute-on-chronic pain management for the sickle cell patient

Additional Information

AttachmentSize
PDF icon Slides and Disclosures2.74 MB
Course summary
Available credit: 
  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Course opens: 
06/01/2021
Course expires: 
06/01/2022
Part of: 
Pharmacotherapy Track
Rating: 
0

image

Thomas B. Gregory, PharmD, BCPS, CPE, FASPE

Clinical Pharmacy Specialist- Pain Management and Emergency Medicine
Cox Health, Springfield, MO
Ozark, Missouri

 

Available Credit

  • 1.00 AAFP
  • 1.00 AANP
  • 1.00 ACCME (All Other)
  • 1.00 ACCME (MD/DO Only)
  • 1.00 ACPE Pharmacy
  • 1.00 ANCC
  • 1.00 APA
Please login or register to take this course.

Required Hardware/software

A computer with an internet connection
Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
Other additional software may be required such as PowerPoint or Adobe Acrobat Reader.